BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 194 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,244,411 | -8.6% | 176,763 | +8.3% | 0.00% | -50.0% |
| Q1 2023 | $1,360,779 | -41.8% | 163,163 | -19.9% | 0.00% | -33.3% |
| Q4 2022 | $2,337,718 | +48.3% | 203,634 | +62.8% | 0.00% | +50.0% |
| Q3 2022 | $1,576,000 | -47.7% | 125,068 | -56.1% | 0.00% | -50.0% |
| Q2 2022 | $3,014,000 | +5.9% | 284,851 | +62.8% | 0.00% | +33.3% |
| Q1 2022 | $2,846,000 | -32.8% | 175,017 | -42.8% | 0.00% | -25.0% |
| Q4 2021 | $4,235,000 | +19.6% | 305,751 | +24.1% | 0.00% | 0.0% |
| Q3 2021 | $3,541,000 | -35.4% | 246,446 | -28.9% | 0.00% | -33.3% |
| Q2 2021 | $5,483,000 | +2816.5% | 346,833 | +598.3% | 0.01% | – |
| Q2 2019 | $188,000 | – | 49,667 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $62,538,000 | 25.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,733 | $27,979,000 | 5.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 57,000 | $19,282,000 | 4.35% |
| MPM BioImpact LLC | 639,089 | $10,392,000 | 2.79% |
| Parkman Healthcare Partners LLC | 476,978 | $7,756,000 | 2.27% |
| Sarissa Capital Management LP | 1,390,790 | $22,614,000 | 2.14% |
| Ghost Tree Capital, LLC | 350,000 | $5,691,000 | 1.24% |
| Lisanti Capital Growth, LLC | 662,644 | $10,775,000 | 1.21% |
| Baker Brothers Advisors | 12,710,818 | $206,678,000 | 1.19% |
| Tamarack Advisers, LP | 125,000 | $2,033,000 | 0.96% |